Search

everythinglearnresearchcommunity

for

Search:↓

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

Glycoconjugates help heal hair follicles during skin repair.

The Accu-Chek FlexLink Plus and Accu-Chek LinkAssist Plus make insulin pump use safer, simpler, and more comfortable.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Ferret hair growth starts between 0 and 4 days after melatonin treatment, with cell growth peaking in the hair germ and declining as the hair matures.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

The U.S. soybean industry wanted government help due to foreign competition, while the jojoba industry was growing and expected to stabilize.

Certain sugars increase in some layers of the hair follicle during the middle of the healing process in rats, which may help improve healing.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Surgical skin treatments improved with new methods like laser resurfacing, combined techniques, and better hair and fat removal options.

Sodium metasilicate improved spinal motoneuron recovery after sciatic nerve injury in rats.

Menopause can cause skin issues, and seeing a dermatologist helps.

The most common skin problems in perimenopausal women in South India are infections, eczemas, and acne, possibly worsened by external factors and lifestyle practices.

A woman's hair loss was likely caused by a cream used for skin treatment and improved after she stopped using it.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Leaving non-absorbable sutures in for 6 months reduces scar stretching and width.

The technique improves facial aging signs with a low risk of complications and a recovery time of about 3 weeks.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

A common cause of skin infections in the U.S. is a strain of bacteria resistant to certain antibiotics, and prevention focuses on cleanliness and avoiding close contact.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.